Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The first ever Orthopaedic Surgical Trials Day was held at the Royal College of Surgeons (RCS) this March. The objective of the day was to bring together the orthopaedic surgical research community to present current trials, intended projects and discuss issues that affect surgical trial research in this area.

The first ever Orthopaedic Surgical Trials Day was held at the Royal College of Surgeons (RCS) this March. The objective of the day was to bring together the orthopaedic surgical research community to present current trials, intended projects and discuss issues that affect surgical trial research in this area.

The workshop was  attended by both experienced and novice clinical researchers, surgeons, research nurses and the odd Channel 4 newsreader! Jon Snow gave a talk about the role media can play in promoting clinical research.

NDORMS were well represented at the event, with Head of department Professor Andrew Carr presenting on “Challenges with surgical trials” and Professor David Beard speaking about the 'Can Shoulder Arthroscopy Work?' study (CSAW); Professor Beard also highlighted other studies from the NDORMS Surgical Intervention Trials Unit (SITU) portfolio. Naomi Merritt and Cushla Cooper, from the CSAW study hosted a breakout session in collaboration with colleagues from the University of Bristol; their session focused on the perils of recruiting patients to studies and they presented work from the Qualitative Recruitment Investigation that was included in the CSAW study.

The event showed how far we have come in the world of surgical research and it was very rewarding for the SITU team to see how the increasing portfolio of orthopaedic and plastics trials in the its portfolio (UKUFF, TOPKAT, CSAW, NINJA) has helped shape current orthopaedic surgical trials research. The day also provided an excellent opportunity for the Oxford group to share their knowledge and experience with the wider orthopaedic community and the team are very much looking forward to sponsoring more of these events and, along with a strong partnership with the British Orthopaedic Association unit at York, help move orthopaedic research into the future.

The RCS day was supplemented by a Trauma and Orthopaedics trials day and Trauma Society special interest day hosted by Professor Matt Costa in Warwick. Again, Oxford had good representation with David Beard speaking on behalf of SITU.

The day was sponsored jointly by the RCS, the Oxford Surgical Intervention Trials Unit at NDORMS and the British Orthopaedic Association Orthopaedic Surgery Research Centre (York Trials Unit).

If you have any comments on the day or would like to find out more, please contact Cushla Cooper, SITU Portfolio Manager (Orthopaedics & Plastics).

Similar stories

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

NDORMS joins research partnership to understand links between overlapping long-term conditions

The links between different long-term health conditions will be explored in new research funded with a £2.5million grant from the Medical Research Council.

NDORMS researchers awarded grant for study on the effects of COVID-19 vaccines on long COVID

A team of NDORMS researchers including Doctor Annika Jödicke and Doctor Victoria Strauss have been awarded NIHR funding to carry out a study into the effects of different COVID-19 vaccines on long COVID.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Researchers show the role of cilia in cartilage health

New research shows that disrupting primary cilia in juvenile, adolescent and early adulthood in cartilage stops it maturing correctly, making it more prone to thinning and the potential for osteoarthritis (OA) in later life.

New research could improve quality of life for Psoriatic Arthritis patients

Professors Laura Coates and Dani Prieto-Alhambra will take major roles in a new European Commission project to develop innovative personalised treatment options for people affected by psoriatic arthritis.